Cargando…

A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice

Introduction: Psoriasis is a chronic inflammatory skin disorder characterized by keratinocyte hyperproliferation and differentiation with increased immune cell infiltration. The anti-psoriatic effect of lavender oil has been reported. However, its phytoconstituents, linalool (L) and linalyl acetate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Vineet Kumar, Chanda, Debabrata, Chanotiya, Chandan Singh, Yadav, Narayan Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388787/
https://www.ncbi.nlm.nih.gov/pubmed/35991888
http://dx.doi.org/10.3389/fphar.2022.913174
_version_ 1784770288965124096
author Rai, Vineet Kumar
Chanda, Debabrata
Chanotiya, Chandan Singh
Yadav, Narayan Prasad
author_facet Rai, Vineet Kumar
Chanda, Debabrata
Chanotiya, Chandan Singh
Yadav, Narayan Prasad
author_sort Rai, Vineet Kumar
collection PubMed
description Introduction: Psoriasis is a chronic inflammatory skin disorder characterized by keratinocyte hyperproliferation and differentiation with increased immune cell infiltration. The anti-psoriatic effect of lavender oil has been reported. However, its phytoconstituents, linalool (L) and linalyl acetate (LA), showed a distinctive affinity with psoriasis targets. Objectives: This investigation was aimed to determine the combined effect of L and LA in ameliorating psoriasis-like skin inflammation and its safety in long-term topical uses. Methods: The combined effect of L and LA was compared with their individual effects. The anti-psoriatic activity was performed using imiquimod (IMQ)-induced psoriasis in BALB/c mice and evaluated to reduce PASI and CosCam scores and Th-1 and Th-17 cell-specific cytokine levels. The acute and repeated dose dermal toxicities were investigated as per the OECD guidelines. Results: L and LA combination (LLA) in the 1:1 w/w ratio at 2% concentration showed a synergistic effect. The combination showed 76.31% and 71.29% recovery in PASI and CosCam Scores; however, L2% and LA2% showed 64.28% and 47.61% recovery in PASI and 64.75 and 56.76% recovery in CosCam scores, respectively. It showed >90% and >100% recovery in Th-17 and Th-1 cell-specific cytokines, respectively, and restored epidermal hyperplasia and parakeratosis toward normal compared with psoriatic mice. A marked reduction in NF-κB, cck6, and the IL-17 expression was also observed in the LLA-treated group. This combination was safe in a therapeutically effective dose for 28 days as no significant changes were observed in organ and body weights, liver and kidney parameters, and differential leukocyte counts. Conclusion: This study proves the synergy between L and LA in a 1:1 w/w ratio at 2% in the treatment of psoriasis-like skin inflammation and provides strong scientific evidence for its safe topical use.
format Online
Article
Text
id pubmed-9388787
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93887872022-08-20 A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice Rai, Vineet Kumar Chanda, Debabrata Chanotiya, Chandan Singh Yadav, Narayan Prasad Front Pharmacol Pharmacology Introduction: Psoriasis is a chronic inflammatory skin disorder characterized by keratinocyte hyperproliferation and differentiation with increased immune cell infiltration. The anti-psoriatic effect of lavender oil has been reported. However, its phytoconstituents, linalool (L) and linalyl acetate (LA), showed a distinctive affinity with psoriasis targets. Objectives: This investigation was aimed to determine the combined effect of L and LA in ameliorating psoriasis-like skin inflammation and its safety in long-term topical uses. Methods: The combined effect of L and LA was compared with their individual effects. The anti-psoriatic activity was performed using imiquimod (IMQ)-induced psoriasis in BALB/c mice and evaluated to reduce PASI and CosCam scores and Th-1 and Th-17 cell-specific cytokine levels. The acute and repeated dose dermal toxicities were investigated as per the OECD guidelines. Results: L and LA combination (LLA) in the 1:1 w/w ratio at 2% concentration showed a synergistic effect. The combination showed 76.31% and 71.29% recovery in PASI and CosCam Scores; however, L2% and LA2% showed 64.28% and 47.61% recovery in PASI and 64.75 and 56.76% recovery in CosCam scores, respectively. It showed >90% and >100% recovery in Th-17 and Th-1 cell-specific cytokines, respectively, and restored epidermal hyperplasia and parakeratosis toward normal compared with psoriatic mice. A marked reduction in NF-κB, cck6, and the IL-17 expression was also observed in the LLA-treated group. This combination was safe in a therapeutically effective dose for 28 days as no significant changes were observed in organ and body weights, liver and kidney parameters, and differential leukocyte counts. Conclusion: This study proves the synergy between L and LA in a 1:1 w/w ratio at 2% in the treatment of psoriasis-like skin inflammation and provides strong scientific evidence for its safe topical use. Frontiers Media S.A. 2022-08-05 /pmc/articles/PMC9388787/ /pubmed/35991888 http://dx.doi.org/10.3389/fphar.2022.913174 Text en Copyright © 2022 Rai, Chanda, Chanotiya and Yadav. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rai, Vineet Kumar
Chanda, Debabrata
Chanotiya, Chandan Singh
Yadav, Narayan Prasad
A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title_full A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title_fullStr A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title_full_unstemmed A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title_short A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
title_sort combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in balb/c mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388787/
https://www.ncbi.nlm.nih.gov/pubmed/35991888
http://dx.doi.org/10.3389/fphar.2022.913174
work_keys_str_mv AT raivineetkumar acombinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT chandadebabrata acombinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT chanotiyachandansingh acombinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT yadavnarayanprasad acombinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT raivineetkumar combinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT chandadebabrata combinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT chanotiyachandansingh combinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice
AT yadavnarayanprasad combinationoflinaloolandlinalylacetatesynergisticallyalleviatesimiquimodinducedpsoriasislikeskininflammationinbalbcmice